Dynamic Changes in High-Sensitivity Cardiac Troponin I in Response to Anthracycline-Based Chemotherapy

AIMS: Treatment advances have improved cancer-related outcomes and shifted interest towards minimising long-term iatrogenic complications, particularly chemotherapy-related cardiotoxicity. High-sensitivity cardiac troponin I (hs-cTnI) assays accurately quantify very low concentrations of plasma trop...

Descripción completa

Detalles Bibliográficos
Autores principales: Tzolos, E., Adamson, P.D., Hall, P.S., Macpherson, I.R., Oikonomidou, O., MacLean, M., Lewis, S.C., McVicars, H., Newby, D.E., Mills, N.L., Lang, N.N., Henriksen, P.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139216/
https://www.ncbi.nlm.nih.gov/pubmed/31813662
http://dx.doi.org/10.1016/j.clon.2019.11.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139216/
https://www.ncbi.nlm.nih.gov/pubmed/31813662
http://dx.doi.org/10.1016/j.clon.2019.11.008

Ejemplares similares